Building Biotechnology on 
Facebook Building Biotechnology on LinkedIn

Yali Friedman, Ph.D.
Third Edition, August 2008
20 Chapters, 460 pages
44 figures, 25 Tables, 63 Boxes
Hardcover: US$89.95 ISBN: 978-09734676-5-9
Softcover: US$64.95 ISBN: 978-09734676-6-6

Distributed by Ingram and Baker & Taylor
Also available from Amazon.com

Sign up for publication updates and previews

Email address

Praise for Previous Editions

"The need for a comprehensive guide to understanding the inner workings of corporate biotechnology is very acute ... This book does much to fulfill that role."
Nature Biotechnology
full review

"an impressive compendium of information for people getting started in the biotechnology industry."
BioExecutive International

"written in plain terms readily accessible to lay readers ... a sound foundation for better understanding this exciting and rapidly changing line of commerce and highly recommended especially to visionary entrepreneurs with a keen interest in this challenging field."
Midwest Book Review

"A very valuable, readable, clear, comprehensive and up to date guide of the biotechnology industry. Building Biotechnology is a must read for investors, reporters, directors and other laymen that wish to understand the fundamentals of the biotechnology business."
William A. Haseltine, Ph.D.
Former Chairman & CEO, Human Genome Sciences

Also available in online classes:


Biotechnology online classes, bootcamps, and seminars

See also

Building the Case for Biotechnology
Management Case Studies in Science, Laws, Regulations, Politics, and Business
Building Biotechnology

Paperback: $64.95

Hardcover: $89.95

Also available from Amazon.com and other book retailers:

Bookstores and volume orders contact info@buildingbiotechnology.com

Scientists know science; businesspeople know business.
This book explains both.

As biotechnology changes paradigms in medicine, agriculture, and industrial processes, there is a pressing need for cross-trained individuals capable of developing new innovations and bringing them to market. Building Biotechnology helps readers start and manage biotechnology companies and understand the business of biotechnology. This acclaimed book describes the convergence of scientific, political, regulatory, and commercial factors that drive the biotechnology industry and define its scope.

In addition to its popularity among business professionals and scientists seeking to apply their skills to biotechnology, Building Biotechnology has also been adopted as a course text in dozens of advanced biotechnology programs including MBA programs at UC Irvine, Tepper, and Boston University; the Johns Hopkins biotechnology MS/MBA program; NIH Office of Technology Transfer; extension programs at Berkeley and UCSF; and international programs at the Karolinska Institute, Macquarie University, and Schulich School of Business.

This third edition significantly expands upon the foundation laid by the first two, updating case law and business models in this dynamic industry and adding significantly more case studies, informative figures and tables. Most importantly, Building Biotechnology enables seasoned business professionals and entrepreneurial scientists alike to understand the drivers of biotechnology businesses and apply their established skills for commercial success.

What makes Building Biotechnology different?

Building Biotechnology builds a robust foundation by providing a comprehensive fundamentals-based overview of the broad variety of elements influencing the commercialization of biotechnology. Expanding on this foundation to ensure a practical appreciation of operational issues in the biotechnology industry, Building Biotechnology adds real-world examples on topics such as the hidden pitfalls of common operational decisions; practical considerations in selecting business models and funding options; strategies to overcome developmental failures; and, methods to leverage options to strengthen development plans.

Biotech Blog

Building Biotechnology is a product of thinkBiotech